NAVIGATION

Emergency Medicine Cardiac Research and Education Group




ACTION Registry
ACTION Registry®–GWTG™ is a national, risk-adjusted, outcomes-based quality improvement program that helps participating facilities measure and improve care for high-risk ACS patients with STEMI and NSTEMI. The result of the collaboration between the two leading national coronary artery disease registries, the NCDR® ACTION Registry® and the American Heart Association (AHA) Get With The GuidelinesSM-CAD Registry, ACTION Registry–GWTG will be the largest, most comprehensive national cardiovascular patient database ever developed by the medical profession.

Combining the strengths of the two programs, ACTION Registry–GWTG will collect a comprehensive set of data elements that provide healthcare professionals and their facilities with the information they need to monitor and improve adherence to the most current, science-based ACC/AHA treatment guidelines. Participation will greatly facilitate quality improvement efforts, optimize clinical care, and improve clinical outcomes for acute coronary syndrome patients.

Visit How To Join to request additional information or to download an enrollment package. Or, visit the ACTION website for more information.



LEGAL INFORMATION
Intellectual Property Rights:
The contents of this Web site are copyrighted. EMCREG-International (collectively, the "Company"), hereby authorize you to copy documents published on this Web site for non-commercial personal use only, provided that any copy of these documents which you make shall retain all copyright and other proprietary notices and any disclaimer contained on the documents. Except as expressly provided above, you may not otherwise copy, display, download, distribute, modify, reproduce, republish or retransmit any information, text or documents contained in this Web site or any portion thereof in any electronic medium or in hard copy, or create any derivative work based on such images, text or documents, without the express written consent of the Company. No information or statement contained herein shall be construed as conferring by implication or otherwise any license or right under any patent, copyright, trademark or other intellectual property right of the Company, or its affiliates, or any third party. Except as expressly provided above, no information or statement contained herein shall be construed as conferring any license or right under any EMCREG patent, copyright or trademark.

Disclaimers
The Company has undertaken reasonable efforts to include accurate and up-to-date information on its Web site. However, THIS WEB SITE IS PROVIDED "AS IS" AND THE COMPANY MAKES NO REPRESENTATIONS OR WARRANTIES, EITHER EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR NON-INFRINGEMENT. THE COMPANY DOES NOT WARRANT THAT THE FUNCTIONS CONTAINED IN THE WEB SITE WILL BE UNINTERRUPTED OR ERROR FREE OR THAT THE WEB SITE OR THE SERVER THAT MAKES IT AVAILABLE ARE FREE OF VIRUSES OR OTHER HARMFUL COMPONENTS. SOME JURISDICTIONS DO NOT ALLOW THE EXCLUSION OF IMPLIED WARRANTIES, SO THE ABOVE EXCLUSION MAY NOT APPLY TO YOU. All users agree that all access and use of this Web site and its content is at their own risk. Neither the Company nor any other party involved in creating, producing or delivering this Web site shall be liable in any manner for any direct, incidental, consequential, indirect or punitive damages arising out of your access, use or inability to use this Web site, or any errors or omissions in the content. This Web site may provide links or references to other Internet sites maintained by third parties over whom the Company has no control. Such links are provided merely as a convenience to users of this Web site. The Company takes no responsibility for the content of such sites and makes no representations as to the accuracy or completeness of any information contained in such sites, and shall have no liability for any damages or injuries of any kind arising from such content or information.

This Website, as well as the contents of this Website, including all information, text, graphics, images, hyperlinks and other material including user contributions (the "Materials"), are for general educational purposes only and are not intended to be used for the purposes of providing medical treatment or attention or making medical or health-related decisions. This Website is not a substitute or replacement for medical advice. If you are seeking medical advice, we encourage you to consult a physician or other medical professional.

The Company, its affiliates, agents, directors, editors, employees, licensors, officers and web sponsors (collectively, the "EMCREG Entities") do not endorse any statements or opinions made in the Materials. EMCREG makes no claim to expert knowledge in the fields of medicine, pharmacology, diagnostic imaging, physiology or any other health-related field and is not able to determine the truthfulness, accuracy, reliability, currency or completeness of the Materials.

EMCREG will attempt, where possible, to identify on the Website the authorship of the Materials. However, such information may not be possible to verify and there can be no assurance that such identification will be accurate in all cases.

The EMCREG Entities do not take any responsibility for the Materials and will not be responsible for any damages to users of the Website, however caused. The views expressed in the Materials are those of the authors and are not necessarily those of the EMCREG Entities. Information in the Materials may not be current and may be superseded by more recent information published by EMCREG or by other parties. USE OF THE WEBSITE OR ITS MATERIALS AND ANY RELIANCE ON THEM WILL BE AT YOUR OWN RISK.

No Warranties or Liability
The EMCREG Entities make no representations or warranties of any kind regarding this Website or the Materials, all of which are provided on an "AS IS" and "WHEN AVAILABLE" basis. The EMCREG Entities disclaim all representations and warranties, including any implied warranties and conditions of merchantable quality, non-infringement and fitness for a particular purpose, including, without limiting the foregoing, the suitability of the Materials as a basis for medical decisions. The EMCREG Entities make no representation or warranty as to the accuracy, reliability, veracity, completeness or suitability of the Materials or about the results to be obtained using the Materials.

IN NO EVENT WILL THE EMCREG ENTITIES BE LIABLE TO YOU OR ANYONE ELSE FOR ANY DECISION MADE OR ACTION TAKEN (OR NOT TAKEN) BY YOUR IN RELIANCE ON THE MATERIALS POSTED TO THIS WEBSITE.

Links to Other Sites
This Website may contain links to other Websites which are provided solely as a convenience to you and not as an endorsement, recommendation or certification by the EMCREG Entities of the contents of such other Websites. The EMCREG Entities will not be responsible for the content of any such Websites (including, without limitation, those sites that provide links to this Website) and do not make any representations or warranties regarding any other Websites or the contents or materials on such Websites. If you decide to access other Websites, you do so solely at your own risk.

Indemnity
You agree to defend, indemnify and hold harmless the EMCREG Entities, as well as any third parties mentioned at this Website, from and against any and all claims, actions or demands, including without limitation reasonable legal and accounting fees, arising out of or resulting from your use of the Website and the Materials or your breach of these Terms and Conditions.






Legal information

EMCREG™ - International
4555 Lake Forest Drive
Suite 650
Cincinnati, Ohio 45242

Fell free to contact us toll-free at 1-866-4EMCREG (436-2734)



Advanced Search

5 March 2010
Computed tomography angiography provides important additional prognostic information, but it's role in clinical practice is still not known.
11 February 2010
Researchers report that a novel method for using natriuretic-peptide testing can optimize postdischarge therapy after acute heart-failure decompensation, reduce hospitalization, and improve outcomes.
28 January 2010
Study results show that the TIMI risk score predicts outcomes in emergency department with suspected ACS.
28 January 2010
Serial measurement of NT-proBNP predicts new-onset heart failure and cardiovascular mortality in elderly.
15 January 2010
Results of the PLATO trial show that the reversible P2Y12 inhibitor ticagrelor reduces death and cardiovascular events compared with clopidogrel therapy in ACS patients.
15 January 2010
Individual risk profiling of ACS patients could optimize therapeutic treatment choices.
5 January 2010
Study shows that high sensitive cardiac troponin I level is a useful prognostic marker of mortality in chronic heart failure patients.
23 December 2009
The largest and most comprehensive meta-analysis ever concludes that CRP is unlikely to be a causal factor for cardiovascular disease.
16 December 2009
Research shows that a substantial number of STEMI patients still receive fibrinolytic therapy at PCI capable centers.
11 December 2009
Denmark researchers report in Lancet that relative risk for hospitalization for bleeding increased with all drug combinations and with each additional drug used.
3 December 2009
Researchers report that prehospital triage significantly reduces treatment delay and improves outcomes in STEMI patients who undergo PCI.
30 November 2009
Researchers report that the to reperfusion, beginning with symptom onset time, determines the extent of reversible myocardial injury in STEMI patients undergoing PCI.
NEWS ARCHIVES:
©Copyright EMCREG-International™. All rights reserved